Efficacy of Angoembolization on post PCNL persistent Hematuria

Phase 2

Recruiting

• Conditions: injury of renal blood vessels post PCNL.; Injury of renal blood vessels; S35.4

• Registration Number: IRCT20230715058782N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Persistent Hematuria after PCNL
Hemoglobin drop needing transfusion
Delayed persistent hematuria

Exclusion Criteria

hypotension
allergy to iodine contrast
coagulopathy
contraindication for iodine contrast
patient refusal

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hematuria cessation. Timepoint: daily control after angioembolization. Method of measurement: urine appearance.;Serum creatinine. Timepoint: before and 2days after angioembolization. Method of measurement: laboratory.;Hemoglobin. Timepoint: before and daily after angioembolization. Method of measurement: Laboratory.;Packed RBC need for hemodynamic stability. Timepoint: before and after angioembolization. Method of measurement: transfused Packed cell.;Angiographic complications. Timepoint: After angioembolization. Method of measurement: complications related to angioembolization detected by sonography.;Need to operation for bleeding control. Timepoint: daily after angioembolization. Method of measurement: Operation for control of hematuria.